Literature DB >> 14991159

[Primary prevention of cardiovascular diseases. Stepchild of internal medicine].

E Windler1, B-Chr Zyriax, F U Beil, H Greten.   

Abstract

Preventive medicine has not been adequately established in our health care system. Despite growing in-sight into the causes underlying arteriosclerotic cardiovascular disease, half of the population dies and even more suffer from it. Generally the correction of risk factors is regarded as causal therapy. Modification of the lipid and carbohydrate metabolism or the blood pressure are certainly effective, however, intervention trials have also demonstrated the limitations. Mostly an unhealthy lifestyle underlies these risk factors so that correction of the lifestyle is the causal therapy in the true sense. That is the principle basis for primary prevention, while pharmacotherapy can only be an adjunct. Inadequate nutrition, physical inactivity and smoking are considered the true major risk factors in our society. Changes in nutrition in favor of plant products, some physical activity and refraining from smoking can serve an effective contribution to health. In the future not only medical, but also economic requirements will increasingly force us to establish prevention on the basis of lifestyle changes as a mainstay of medicine.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14991159     DOI: 10.1007/s00108-003-1130-2

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  52 in total

1.  Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.

Authors:  R B D'Agostino; S Grundy; L M Sullivan; P Wilson
Journal:  JAMA       Date:  2001-07-11       Impact factor: 56.272

2.  Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women.

Authors:  J Stamler; R Stamler; J D Neaton; D Wentworth; M L Daviglus; D Garside; A R Dyer; K Liu; P Greenland
Journal:  JAMA       Date:  1999-12-01       Impact factor: 56.272

3.  Hemostatic, metabolic, and androgenic risk factors for coronary heart disease in physically active and less active postmenopausal women.

Authors:  E T Stevenson; K P Davy; D R Seals
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-05       Impact factor: 8.311

4.  Physical activity and coronary heart disease in women: is "no pain, no gain" passé?

Authors:  I M Lee; K M Rexrode; N R Cook; J E Manson; J E Buring
Journal:  JAMA       Date:  2001-03-21       Impact factor: 56.272

5.  Nutrient intake and progression of coronary artery disease.

Authors:  G F Watts; P Jackson; S Mandalia; J N Brunt; E S Lewis; D J Coltart; B Lewis
Journal:  Am J Cardiol       Date:  1994-02-15       Impact factor: 2.778

6.  Decline in the risk of myocardial infarction among women who stop smoking.

Authors:  L Rosenberg; J R Palmer; S Shapiro
Journal:  N Engl J Med       Date:  1990-01-25       Impact factor: 91.245

7.  Smoking and myocardial infarction.

Authors:  C Wilhelmsson; J A Vedin; D Elmfeldt; G Tibblin; L Wilhelmsen
Journal:  Lancet       Date:  1975-02-22       Impact factor: 79.321

8.  Prevalence of conventional risk factors in patients with coronary heart disease.

Authors:  Umesh N Khot; Monica B Khot; Christopher T Bajzer; Shelly K Sapp; E Magnus Ohman; Sorin J Brener; Stephen G Ellis; A Michael Lincoff; Eric J Topol
Journal:  JAMA       Date:  2003-08-20       Impact factor: 56.272

9.  High-density lipoprotein cholesterol and other risk factors for coronary heart disease in female runners.

Authors:  P T Williams
Journal:  N Engl J Med       Date:  1996-05-16       Impact factor: 91.245

10.  Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial.

Authors:  D Ornish; S E Brown; L W Scherwitz; J H Billings; W T Armstrong; T A Ports; S M McLanahan; R L Kirkeeide; R J Brand; K L Gould
Journal:  Lancet       Date:  1990-07-21       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.